ISS [iSoftStone] F-6EF: ____________________ FORM F-6 REGISTRATION STATEMENT UNDER THE SECURITIES

[____________________ FORM F-6 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 For Depositary Shares Evidenced by American Depositary Receipts ___________________ iSoftStone Holdings Limited (Exact name of issuer of deposited securities as specified in its charter) n/a Cayman Islands (Jurisdiction of incorporation or organization of issuer) JPMORGAN CHASE BANK, N.A. (Exact name of depositary as specified in its charter) 1 Chase] [(1) Issuance and Pre-Release of ADSs. 2 (2) Withdrawal of Deposited Securities. (3) Transfers of ADRs. provided provided 3 (4) Certain Limitations. provided (5) Taxes. 4] [Ziegler, Ziegler & Associates LLP Counselors at Law th 570 Lexington Avenue, 44 New York, New York 10022 (212) 319-7600 Telecopier (212) 319-7605 November 7, 2011 JPMorgan Chase Bank, N.A., as Depositary 1 Chase Manhattan Plaza, Floor 21 New York, New York 10005 American Depositary Shares evidenced by American Depositary Receipts for deposited ordinary shares of iSoftStone Holdings Limited Dear] [Certification under Rule 466 The depositary, JPMorgan Chase Bank, N.A. represents and certifies the following: (1) That it previously had filed a registration statement on Form F-6 (iSoftStone Holdings Limited 333-170867) that the Commission declared effective, with terms of deposit identical to the terms of deposit of this registration statement. (2) That its ability to designate the date and time]

By | 2016-03-23T05:20:37+00:00 November 7th, 2011|Categories: Chinese Stocks, ISS, Webplus ver|Tags: , , , , , |0 Comments

NTES [NetEase] CORRESP: (Original Filing)

[The Staffs comment is noted, and the Company will include disclosure in Item 5 of its annual report on Form20-F for the year ending December31, 2011 regarding the need to accrue and pay withholding or other taxes if funds are repatriated and the Companys current plans with respect to repatriation of funds.]

By | 2016-01-11T11:31:25+00:00 November 7th, 2011|Categories: Chinese Stocks, NTES, SEC Original|Tags: , , , , , |0 Comments

CBPO [China Biologic Products] 8-K: (Original Filing)

[Company Contact FOR RELEASE ON NOVEMBER 7, 2011 AT 4:20 p.m. EST (New York) China Biologic Reports Third Quarter 2011 Results TAI'AN, Shandong Province, China, November 7, 2011 – China Biologic Products, Inc. (NASDAQ: CBPO) (“China Biologic” or the “Company”), one of the leading plasma-based biopharmaceutical companies in the People’s Republic of China (“PRC”), today reported its financial results for] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): November 7, 2011 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) No. 14 East Hushan Road, Tai'an City, Shandong, 271000 People's Republic of China 86-538 -620-2306 ____________________________________________________________ (Former name or former address, if changed]

Skip to toolbar